Literature DB >> 23124042

GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation.

Xianmin Bu1, Chenghai Zhao, Wei Wang, Ning Zhang.   

Abstract

Gastric cancer is one of the most common malignancies, and radiation resistance is one of the key obstacles in gastric cancer treatment. In this study, we demonstrate that "genes associated retinoid-IFN induced mortality-19" (GRIM-19) expression was lower in patients with radiotherapy-resistant tumors compared to patients with radiotherapy-sensitive tumors. In order to further investigate the effects of GRIM-19 expression on the radiation response in gastric cancer cells, we established BGC-803 clones stably expressing exogenous GRIM-19. We found that the percentage of apoptotic cells was higher in cells expressing GRIM-19 than untransfected cells post-radiation treatment. Furthermore, caspase-3, -8, and -9 activity was significantly increased in GRIM-19-expressing cells compared to untransfected cells after radiation. Finally, we demonstrate that expression of GRIM-19 in BGC-803 cells suppresses accumulation of STAT3. Collectively, these data show that GRIM-19 expression sensitizes BGC-803 cells to radiation, and this is likely due to suppression of STAT3 accumulation. In summary, our results indicate that GRIM-19 expression might be a useful therapy to enhance apoptosis in gastric cancer cells in response to radiation treatment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124042     DOI: 10.1016/j.gene.2012.10.057

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Mitoneet mediates TNFα-induced necroptosis promoted by exposure to fructose and ethanol.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Cell Sci       Date:  2013-12-19       Impact factor: 5.285

2.  GRIM-19 deficiency promotes clear cell renal cell carcinoma progression and is associated with high TNM stage and Fuhrman grade.

Authors:  Naimeng Yan; Xue Feng; Sixiong Jiang; Weibin Sun; Ming-Zhong Sun; Shuqing Liu
Journal:  Oncol Lett       Date:  2020-03-31       Impact factor: 2.967

3.  STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Qu Zhang; Chi Zhang; Jia He; Qing Guo; Desheng Hu; Xi Yang; Jinfeng Wang; Yahui Kang; Ruifang She; Zhongming Wang; Defan Li; Guanhong Huang; Zhaoming Ma; Weidong Mao; Xiaoyi Zhou; Chuangying Xiao; Xinchen Sun; Jianxin Ma
Journal:  Tumour Biol       Date:  2014-12-10

Review 4.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

5.  High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.

Authors:  Yong-Guang Li; Bei-Bei Han; Feng Li; Jian-Wu Yu; Zhi-Feng Dong; Geng-Ming Niu; Yan-Wei Qing; Jing-Bo Li; Meng Wei; Wei Zhu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

6.  In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma.

Authors:  Hongmei Zhu; Shu Ruan; Feng Jia; Jiusheng Chu; Yong Zhu; Yongjiu Huang; Guan Liu
Journal:  Onco Targets Ther       Date:  2018-11-14       Impact factor: 4.147

7.  Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells.

Authors:  Chenxi Hu; Wei Zhuang; Yun Qiao; Bin Liu; Liang Liu; Kaiyuan Hui; Xiaodong Jiang
Journal:  Onco Targets Ther       Date:  2019-01-29       Impact factor: 4.345

Review 8.  STAT3 Contributes to Radioresistance in Cancer.

Authors:  Xuehai Wang; Xin Zhang; Chen Qiu; Ning Yang
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

Review 9.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

10.  MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway.

Authors:  Ningning He; Yangyang Kong; Xudan Lei; Yang Liu; Jinhan Wang; Chang Xu; Yan Wang; Liqing Du; Kaihua Ji; Qin Wang; Zongjin Li; Qiang Liu
Journal:  Cell Death Dis       Date:  2018-10-08       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.